Food and Drug Law Weekly

Biolex Therapeutics - Biolex Therapeutics announces positive phase I results for hepatitis C drug candidate Locteron

Bionor Immuno AS - Delayed-type hypersensitivity can monitor reactions to HIV-1 vaccine

Boston University - Antitumor prodrug gene therapy is enhanced using a low K_m cyclophosphamide

Brigham & Women's Hospital, Boston - IIb/IIIa antagonists may improve procedural outcome during saphenous vein graft stenting

Business Update - Claimsnet announces contract with Medicare healthcare plan

Buskerud Hospital, Drammen - Norwegian rectal cancer patient outcomes after surgery described

Campus Bio-Medico University, Rome - Rectal cancer prognosis after surgery reviewed

Case Western Reserve University, Cleveland - Insulin therapy improves free radical damage and mitochondrial function in diabetic heart

Cell Therapeutics, Inc. - Cell Therapeutics, Inc. issues public offering of $33.2 million in convertible senior notes

Centre Hospitalier Luxembourg - For severe chronic ischemic HF, cell therapy may improve cardiac deformation, mitral regurgitation

Centre Hospitalier Universitaire, Nimes - Predictors of retroperitoneal sarcoma recurrence delineated

Charite Campus Virchow Klinikum - Researchers' data from Germany, Iran and the United States advance transplants research

Chiba University - Lung cancer diagnosed by transbronchial fine needle aspiration cytology

Chung Shan Medical University Hospital, Taichung - Methicillin-resistant Staphylococcus aureus infection enhanced inflammation and coagulation

Churchill Hospital, Oxford - Studies from the United Kingdom, United States and Italy describe new findings in surgery research

CombinatoRx, Incorporated - CombinatoRx receives infectious disease research grant approval in Singapore

Cook Incorporated - Cook Inc.'s Zenith Fenestrated Endograft reaches 1,000th endovascular aortic repair

Cytogen Corporation - Cytogen and Savient finalize exclusive distribution agreement for SOLTAMOX

Cytokinetics, Incorporated - Cytokinetics, Incorporated reports first quarter financials, company highlights

Cytori Therapeutics, Inc. - Cytori studies using adipose stem and regenerative cells in breast reconstruction

DURECT Corporation - DURECT provides update on its post-operative Pain Depot (SABER-Bupivacaine) program

Dana Farber/Partners Cancer Care Program, Boston - Ovarian cancer therapy with irofulven is associated with retinal toxicity

Department of VA New Jersey Healthcare Systems - Researchers from the United States and United Kingdom report recent findings in diabetes

Diet & Nutrition - Ronzoni Healthy Harvest reformulates pasta line to include more whole grains

Diet & Nutrition - World Health Organization releases new standards for how all children should grow

Dokuz Eylul University, Izmir - Weight gain is related to worse renal functions but not greater proteinuria levels

Dwight D Eisenhower Army Medical Center - Sildenafil enhances skin flap survival in rats

Dynavax Technologies Corporation - Dynavax announces slight increase in first-quarter revenue, provides performance update

Kensey Nash Corporation - U.S. FDA grants 510(k) clearance for Kensey Nash's thrombectomy catheter system

PhotoCure ASA - U.S. FDA requests more information related to Hexvix NDA

Stem Cell Therapeutics Corp. - Stem Cell Therapeutics enters agreement to support phase 2a safety study of stroke therapy

Taro Pharmaceutical Industries Ltd. - Taro receives tentative ANDA approvals for carvedilol tablets, ondansetron HCL tablets

U.S. Food & Drug Administration - Research from the United States in proteins provides new insights

U.S. Food and Drug Administration - Reaction of geldanamycin analogues with glutathione produces potential anticancer agents

U.S. Food and Drug Administration - U.S. FDA advances federal e-health effort

University of California, Davis - West Nile virus persists in Southern California by three mechanisms